Core Viewpoint - Changjiang Garment (00294.HK) reported a loss of HKD 53.31 million for the six months ending September 30, 2025, primarily due to losses from its investment in Wuxi Cotton Investment Co., which accounted for HKD 47.74 million of the losses [1] Financial Performance - The company's revenue for the review period was approximately HKD 85.59 million [1] - The loss for the first six months of 2024/25 was HKD 31.77 million, indicating a worsening financial situation year-over-year [1] Business Operations - The core garment business showed improvement compared to the same period last year, with increased revenue and reduced losses [1] - However, the company anticipates ongoing challenges for its garment business for the remainder of the fiscal year [1] - The investment in Wuxi Cotton is expected to continue to pose significant losses for the company [1]

Financial Performance - Revenue for the six months ended September 30, 2025, was HKD 85,593,000, representing an increase of 13.3% compared to HKD 75,301,000 for the same period in 2024[4] - Gross profit for the same period was HKD 15,089,000, up from HKD 13,511,000, indicating a growth of 11.7%[4] - The operating loss decreased to HKD 5,437,000 from HKD 7,751,000, showing an improvement of 30%[4] - The net loss attributable to equity holders for the period was HKD 53,314,000, compared to HKD 31,773,000 in the previous year, reflecting a significant increase in losses[4] - Basic and diluted loss per share was HKD 0.26, compared to HKD 0.15 for the same period last year[4] - The group reported a loss before tax of HKD 53,688,000 for the six months ended September 30, 2025, compared to a loss of HKD 32,180,000 in the same period of 2024[14] - The company reported a total comprehensive loss of HKD 42,730,000 for the period, compared to HKD 14,145,000 in the previous year[5] - The company recorded a gross profit of HKD 15,089,000, up 12% from HKD 13,511,000 year-on-year, maintaining a gross margin of 18%[32] - Operating loss improved by 30% to HKD 5,437,000 from HKD 7,751,000 in the previous year, with an operating margin of -6% compared to -10%[32] Assets and Liabilities - Total assets decreased to HKD 924,167,000 from HKD 974,508,000, a decline of 5.2%[6] - The group’s total assets as of September 30, 2025, were HKD 1,011,596,000, a decrease from HKD 1,049,570,000 as of March 31, 2025[13] - Current liabilities increased to HKD 63,891,000 from HKD 49,767,000, representing a rise of 28.4%[6] - Inventory levels rose significantly to HKD 17,582,000 from HKD 8,734,000, an increase of 101.0%[6] - Accounts receivable and other receivables totaled HKD 32,145,000 as of September 30, 2025, an increase from HKD 24,375,000 as of March 31, 2025[27] - The company had no short-term or long-term borrowings as of September 30, 2025[34] Revenue Sources - Revenue from garment manufacturing and sales was HKD 84,064,000, up 15% from HKD 73,088,000 in the previous year[11] - Revenue for the six months ended September 30, 2025, was HKD 85,593,000, an increase of 13.4% compared to HKD 75,301,000 for the same period in 2024[11] - The group’s revenue from external customers in Europe was HKD 59,232,000, a decrease from HKD 66,078,000 in the previous year[16] - Total rental income from investment properties decreased to HKD 1,507,000 from HKD 1,836,000, a decline of 17.9%[11] Investment Properties - The valuation loss on investment properties was HKD 243,000, compared to HKD 8,957,000 in the previous year, indicating a substantial reduction in losses[4] - The group reported a net loss from investment property valuation of HKD 243,000, compared to a loss of HKD 8,957,000 in the previous year[14] - The company recorded a net valuation loss related to investment properties of HKD 243,000 for the period, significantly lower than the valuation loss of HKD 8,957,000 for the same period in 2024[26] Dividends and Shareholder Information - The group did not declare an interim dividend for the six-month period ended September 30, 2025, compared to no dividend declared in the same period of 2024[19] - The company did not declare an interim dividend for the six months ended September 30, 2025, compared to no dividend declared in the same period of 2024[31] - The interim report for the six months ending September 30, 2025, will be sent to shareholders and published on the company's website[42] - The company is committed to transparency and will continue to publish performance announcements on the Hong Kong Stock Exchange website[42] Corporate Governance - The board of directors consists of six executive directors and three independent non-executive directors[43] - The company employed approximately 133 employees as of September 30, 2025, with compensation packages based on performance and market salary levels[37] - The company has adopted a securities trading code for directors that meets or exceeds the standards set out in the Listing Rules Appendix C3[41] - All directors have confirmed compliance with the securities trading code during the review period[41] Financing Costs - The group incurred financing costs of HKD 271,000, down from HKD 345,000 in the previous year[14] - The company’s cash and cash equivalents as of September 30, 2025, were approximately HKD 318,924,000, down from HKD 332,136,000 as of March 31, 2025[34]

Group 1 - The board of directors of Changjiang Garment (00294.HK) will hold a meeting on November 21, 2025, to approve the unaudited consolidated results for the six months ending September 30, 2025 [1] - The meeting will also consider the declaration of an interim dividend, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不會就本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 長 江 製 衣 有 限 公 司 ( 於 香 港 註 冊 成 立 之 有 限 公 司 ) (股 份 代 號 ： 00294) 董 事 會 會 議 通知 長江製衣有限公司(｢本公司｣)之董事會(｢董事會｣)謹此宣佈，董事會將於二零二 五年十一月二十一 日(星期五)下午四時正在香港九龍新蒲崗大有街22號舉行會 議，旨在(當中包括)批准本公司及其附屬公司截至二零二五年九月三十日止六個 月之未經審核綜合業績及其發佈，以及考慮派付中期股息(如有)。 承董 事 會命 長 江 製 衣 有 限公 司 公司 秘 書 許 秀 玲 香港 ， 二零 二五年 十一 月 七日 於本公告日期，董事會包括六位執行董事，為陳永奎先生、陳永棋先生、陳永滔先生、劉陳淑文女士、陳 永燊先生及周陳淑玲女士，及三位獨立非執行董事，為蔡廷基先生、蘇漢章先生及李光明先生。 YANGTZEKIANG GARMENT LIMITED ...

FF301 II. 已發行股份及/或庫存股份變動 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年10月31日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 長 江 製 衣 有 限 公 司 | | | | 呈交日期: | 2025年11月3日 | | | | I. 法定/註冊股本變動 | 不適用 | | | | 備註： | | | | | 自《公司條例》(香港法例622章)於2014年3月3日生效後，本公司(於香港註冊成立的公司)不再有法定股本及股份面值。 | | | | FF301 第 1 頁 共 10 頁 v 1.1.1 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00294 | 說明 | | | | | | | | | | 已發行股 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 長 江 製 衣 有 限 公 司 | | | 呈交日期: | 2025年10月2日 | | | I. 法定/註冊股本變動 不適用 | | | | 備註： | | | | 自《公司條例》(香港法例622章)於2014年3月3日生效後，本公司(於香港註冊成立的公司)不再有法定股本及股份面值。 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 | 1. 股份分類 | | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號(如上市) | | 00294 | | 說明 | | | | | | | | 股份期權計劃詳情 | | 上月底結存的股份期權數 目 | | 本月內變 ...

（於香港註冊成立之有限公司） (股份代號： 00294) 於 二 零 二 五 年 九 月 二 十 六 日 舉 行 之 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示概不就因本公佈全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔 任何責任。 長 江 製 衣 有 限 公 司 YANGTZEKIANG GARMENT LIMITED 所有董事均已親身或透過電子方式出席股東週年大會。 於股東週年大會上提呈之各項決議案按股數投票結果如下：- | | | 普 通 決 議 案 | | 投 票 股 數 (百 分 比 | ) | | --- | --- | --- | --- | --- | --- | | | | | 贊 成 | | 反 對 | | 1. | | | 省覽及考慮截至二零二五年三月三十一日止年度 105,541,870 | | 0 | | | | | 之經審核綜合財務報表、董事會報告書及獨立核 (100%) | | (0%) | | | 數師報告。 | | | | | | 2. | | | 批准及宣派截至二零二五年三月三十一日 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年8月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 長 江 製 衣 有 限 公 司 | | | 呈交日期: | 2025年9月1日 | | | I. 法定/註冊股本變動 | 不適用 | | | 備註： | | | | 自《公司條例》(香港法例622章)於2014年3月3日生效後，本公司(於香港註冊成立的公司)不再有法定股本及股份面值。 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00294 | 說明 | | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股 ...

Core Viewpoint - The stock of Angli Kang (002940) has experienced significant volatility, with a cumulative increase of over 20% in two consecutive trading days, prompting the company to issue a risk warning [1] Group 1: Stock Performance and Trading Activity - Angli Kang's stock price has shown a remarkable upward trend since June, achieving a maximum cumulative increase of 360% during this period [3] - The company has confirmed that there are no undisclosed significant matters affecting its stock price and that its operational status remains normal [1] - The first phase of the employee stock ownership plan holds 4.3311 million shares, accounting for 2.15% of the total share capital, with potential for stock sales before the plan's expiration on November 2, 2025 [5] Group 2: Innovation Drug Projects - The company is currently focused on its ALK-N001 project, which is in Phase I clinical trials as of the announcement date [1] - There is an ongoing interest in the ALK-N002 project, which is still in the candidate selection phase and has not yet finalized specific drug candidates [2] - The company emphasizes the long cycle, high investment, and uncertainty associated with innovative drug development [2] Group 3: Business Overview - Angli Kang's pharmaceutical business includes chemical raw materials, chemical preparations, and pharmaceutical excipients, with a focus on high-purity plant-derived cholesterol and its derivatives [2]

Group 1 - The company Changjiang Garment (00294.HK) announced changes in its board of directors' nomination committee effective from August 1, 2025 [1] - Executive Director Chen Yongqi will no longer serve as a member of the nomination committee [1] - Executive Director Liu Chen Shuwen has been appointed as a member of the nomination committee [1]